SCHEMBL3090925

SCHEMBL3090925

O=C(c1ccc(-c2nnc(-c3ccc4c(c3)OCO4)o2)s1)C(F)(F)F

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 11/20 0.65
HDAC1 Q13547 9/20 0.65
HDAC4 P56524 8/20 0.65
HDAC3 O15379 3/20 0.64
NPC1 O15118 7/20 0.49
RAB9A P51151 7/20 0.49
SMN1; SMN2 Q16637 7/20 0.49
KDM4E B2RXH2 5/20 0.49
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.49
POLB P06746 3/20 0.47
TP53 P04637 4/20 0.46
HSP90AA1 P07900 1/20 0.46
HSD17B10 Q99714 3/20 0.46
TSHR P16473 2/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3086968 0.87 HDAC6 (0.85) HDAC6HDAC1HDAC4HDAC3NPC1
SCHEMBL3094022 0.80 HDAC6 (0.79) HDAC6HDAC1HDAC4HDAC3NPC1
SCHEMBL3098138 0.80 HDAC6 (1.00) HDAC6HDAC1HDAC4HDAC3MAPT
SCHEMBL3104198 0.79 HDAC6 (0.77) HDAC6HDAC1HDAC4HDAC3NPC1
SCHEMBL3093353 0.79 HDAC6 (1.00) HDAC6HDAC1HDAC4HDAC3NPC1
SCHEMBL3098565 0.78 HDAC6 (1.00) HDAC6HDAC1HDAC4HDAC3NPC1
SCHEMBL3086991 0.77 HDAC6 (0.78) HDAC6HDAC1HDAC4HDAC3HDAC7
SCHEMBL3103769 0.75 HDAC6 (0.74) HDAC6HDAC1HDAC4HDAC3NPC1
SCHEMBL3492339 0.74 NPC1 (0.81) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL13154042 0.73 HDAC6 (0.72) HDAC6HDAC1HDAC4HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987024-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-10-19 EP disclosed
US-7799825-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-21 US disclosed
US-20090076101-A1 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors MSD ITALIA S.R.L. (IT) 2009-03-19 US disclosed
EP-1987024-A1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Ricerche di Biologia Molecolare P. Angeletti (IT) 2008-11-05 EP disclosed
WO-2007093827-A1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076101-A1 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC1, HDAC4, HDAC7 HDAC6 10/4885HDAC1 1/4885HDAC4 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.